Triglycerides and carotid intima-media thickness in ischemic stroke patients

- An oral triglyceride tolerance test is safe, inexpensive, and easy to perform.
- Fasting triglyceride levels associate with CCA-IMT.
- Post-challenge triglycerides do not associate with CCA-IMT.
- An oral fat challenge may not add information on atherosclerotic burden.

BackgroundCommon carotid artery intima-media thickness (CCA-IMT) is an established marker for atherosclerosis. The role of triglycerides in CCA-IMT remains controversial. We sought to determine if elevated fasting and post-challenge triglycerides are associated with CCA-IMT.MethodsAll acute ischemic stroke patients who participated in the Berlin “Cream & Sugar” study in the Charité Virchow and Charité Mitte Campuses between January 2009 and January 2014 and underwent carotid artery ultrasound studies were eligible for inclusion. A combined oral glucose and triglyceride tolerance test was performed 3-7 days after first ever ischemic stroke. Patients were classified according to triglyceride metabolism-namely, (1) patients reaching a maximum triglyceride levels 3 h post-challenge (“fast metabolizers,” n = 37), (2) patients with increasing triglycerides 4 (medium metabolizers, n = 64), and (3) 5 h post-challenge (“slow metabolizers,” n = 44; 13 missing).ResultsWe included 158 patients (34% female; mean age 63 years, SD 14). Absolute non-fasting triglyceride levels were positively associated with CCA-IMT. A final multiple regression model revealed that older age, more severe strokes, and higher levels of fasting triglycerides were significantly and independently associated with higher mean CCA-IMT. Older age, higher waist-to-hip ratio, and higher levels of thyroid-stimulating hormone were independently associated with higher maximum CCA-IMT.ConclusionFasting triglycerides but not post-challenge triglycerides associate with CCA-IMT. An oral fat challenge may not add information on atherosclerotic status in ischemic stroke patients.Clinical Trial Registration Information: The Berlin “Cream & Sugar” study is registered with EudraCT (2009-010356-97) and clinicaltrials.gov (NCT 01378468).